Leukocyte function in chronic myeloproliferative disorders

Blood Cells, Molecules, and Diseases

Volumn 24, Issue 4, 1998, Pages 544-551

  Wolach, Baruch ^a   Gavrieli, Ronit ^b   Manor, Yosef ^b   Lishner, Michael ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Bactericidal activity; Myeloproliferative disorders; Neutrophil chemotaxis; Random migration; Serum lysozyme; Superoxide production

Indexed keywords

ALPHA INTERFERON; DANAZOL; HYDROXYUREA; LYSOZYME; NAPROXEN; SUPEROXIDE;

ADULT; AGED; ARTICLE; BACTERICIDAL ACTIVITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MALE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PHAGOCYTOSIS; POLYCYTHEMIA VERA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROMYELOCYTE; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 0032451314     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0218     Document Type: Article

References (27)

1. 1. Corberand J, Laharrague P, De Larrard B, Nguyen F, Pris J. Phagocytosis in myeloproliferative disorders. Am J Clin Pathol 74: 301-305, 1980.
2. 2. Bendix-Hansen K. Myeloperoxidase-deficient polymorphonuclear leukocytes (VII): Incidence in untreated myeloproliferative disorders. Scan J Haematol 36:8-10, 1986.
3. 3. Matzner Y. Neutrophil function in hematological neoplasia. Leuk Lymphoma 4:9-15, 1991.
4. 4. Borregaard N, Kjeldsen L, Sengelov H. Mobilization of granules in neutrophils from patients with myeloproliferative disorders. Eur J Haematol 50:189-199, 1993.
5. 5. Tsurumi H, Shimazaki M, Takahashi T, Moriwaki H, Mulo Y. Flow cytometric determination of active oxigen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders. Int J Hematol 57:213-219, 1993.
6. 6. Samuelsson J, Forslid J, Hed J, Palmblad J. Studies of neutrophil and monocyte oxidative responses in polycythaemia vera and related myeloproliferative disorders. Br J Haematol 87:464-470, 1994.
7. 7. Wolach B, Baehner RL, Boxer LA. Review: Clinical and laboratory approach to the management of neutrophil dysfunction. Isr J Med Sci 18:897-916, 1982.
8. 8. Curnutte JT. Disorders of phagocytic function. In: Hoffman R et al, eds. Hematology, 2nd Ed. Churchill Livingstone Inc, New York, p. 792, 1995.
9. 9. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest 21:77-89, 1963.
10. 10. Falk W, Goodwin RH Jr, Leonard EJ. A 48-well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239-247, 1980.
11. 11. Clawson CC, Repine JE. Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med 88:316-327, 1976.
12. 12. Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC. Human granulocyte macrophage colony-stimulating factor is a neutrophil activator. Nature 314:361-363, 1985.
13. 13. Wright DG, Gallin JI. Secretory responses of human neutrophils: Exocytosis of specific secondary granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol 123:285-294, 1979.
14. 14. Ghosh ML, Hudson G, Blackburn EK. Skin window studies in polycythaemia rubra vera. Br J Haematol 29:461-467, 1975.
15. 15. Samuelsson J, Lindstrom P, Palmblad J. Stimulus-specific defect in oxidative metabolism of polymorphonuclear granulocytes in polycythemia vera. Eur J Haematol 41:454-458, 1988.
16. 16. Brandt L. Adhesiveness to glass and phagocytic activity of neutrophilic leukocytes in myeloproliferative disorders. Scand J Haematol 2:126-136, 1965.
17. 17. Samuelsson J, Berg A. Further studies of the defective stimulus-response coupling for the oxidative burst in neutrophils in polycythemia vera. Eur J Haematol 47:239-245, 1991.
18. 18. Samuelsson J, Hansson A, Rosendahl K, Palmblad J. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-pheny-lalanine stimulation of polymorphonuclear granulo-cytes in polycythemia vera. J Lab Clin Med 121:310-319, 1993.
19. 19. Baker MA, Taub RN, Whelton CH, Hindenburg A. Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia. Blood 63:1194-1197, 1984.
20. 20. Kasimir-Bauer S, Ottinger H, Brittinger G, Konig W. Philadelphia chromosome-positive CML: functional defects in circulating mature neutrophils of untreated and Interferon-treated patients. Exp Hematol 22:426-431, 1994.
21. 21. Whittaker JA, Khurshid M, Hughes HR. Neutrophil function in chronic granulocytic leukemia before and after busulfan treatment. Br J Haematol 28:541-549, 1974.
22. 22. Olofsson T, Odeberg H, Olsson I. Granulocyte function in chronic granulocytic leukemia. II. Bactericidal capacity, phagocytic rate, oxygen consumption and granule protein composition in isolated granulocytes. Blood 48:581-593, 1976.
23. 23. Naik NR, Advani SH, Bhisey AN. PMN cells from chronic myeloid leukemia (CML) patients show defective chemotaxis in remission. Leuk Res 13:959-965, 1989.
24. 24. Kaplan SS, Berkow RL, Joyce RA, Basford RE, Barton JC. Neutrophil function in chronic neutrophilic leukemia: defective respiratory burst in response to phorbol esters. Acta Haematol 87:16-21, 1992.
25. 25. Lanza F, Fagioli F, Gavioli R, Spisani S, Malavasi F, Castoldi GL, Traniello S. Evaluation of CR1 expression in neutrophils from chronic myeloid leukemia: relationship between prognosis and cellular activity. Br J Haematol 77, 66-72, 1991.
26. 26. Anklesaria PN, Advani SH, Bhisey AN: Defective chemotaxis and adherence in granulocytes from chronic myeloid leukemia (CML) patients. Leuk Res 9: 641, 1985.
27. 27. Perianin A, Labro-Bryskier MT, Marquetty C, Hakim J. Glutathione reductase and nitroblue tetrazolium reduction deficiencies in neutrophils of patients with primary idiopathic myelofibrosis. Clin Exp Immunol 57: 244-248, 1984.